Latest news
Loading news…
Internis Pharmaceuticals develops, manufactures, and supplies prescription vitamin D medicines for the United Kingdom market.
Internis Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Internis Pharmaceuticals was acquired by STADA Arzneimittel AG in 2015 for $75.12M.
Total Funding
$3.13M
Funding Rounds
1
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0
About Internis Pharmaceuticals
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- London, England, United Kingdom
Internis Pharmaceuticals Funding Rounds
1 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–1 of 1Show
Page 1 / 1
Internis Pharmaceuticals Key People
Co-Founder & Co-Chief Executive Officer
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Internis Pharmaceuticals
Loading news…
FAQs about Internis Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.